Sabra Healthcare REIT, Inc. $SBRA Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System cut its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 3.8% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 622,962 shares of the real estate investment trust’s stock after selling 24,907 shares during the period. California Public Employees Retirement System owned 0.25% of Sabra Healthcare REIT worth $11,980,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the business. Rothschild Investment LLC boosted its holdings in shares of Sabra Healthcare REIT by 164.6% during the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 889 shares during the last quarter. Smartleaf Asset Management LLC increased its stake in Sabra Healthcare REIT by 97.7% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 714 shares during the last quarter. Strengthening Families & Communities LLC acquired a new position in Sabra Healthcare REIT in the fourth quarter valued at $29,000. Danske Bank A S purchased a new position in Sabra Healthcare REIT during the third quarter worth about $30,000. Finally, Larson Financial Group LLC lifted its position in Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after buying an additional 553 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Performance

Shares of NASDAQ:SBRA opened at $22.36 on Friday. The business has a 50-day moving average of $19.68 and a two-hundred day moving average of $19.84. The firm has a market capitalization of $5.64 billion, a PE ratio of 35.49, a P/E/G ratio of 1.57 and a beta of 0.65. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72. Sabra Healthcare REIT, Inc. has a 12 month low of $17.17 and a 12 month high of $22.55.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, meeting the consensus estimate of $0.16. The business had revenue of $211.74 million for the quarter, compared to analyst estimates of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The company’s revenue was up 20.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 5.4%. The ex-dividend date was Friday, May 15th. Sabra Healthcare REIT’s payout ratio is currently 190.48%.

Wall Street Analysts Forecast Growth

SBRA has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Sabra Healthcare REIT in a report on Wednesday. Wells Fargo & Company increased their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a report on Monday, June 1st. Citigroup reissued a “market outperform” rating on shares of Sabra Healthcare REIT in a research report on Wednesday. Cantor Fitzgerald boosted their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a report on Monday, May 11th. Finally, Scotiabank dropped their price target on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating for the company in a research report on Thursday, June 18th. Eight analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $22.25.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.